Hepatitis Test Solution/Diagnosis Market Size, Share, Growth, and Industry Analysis, By Type (Hepatitis B, HCV, HAV, HDV, Others), By Application (Hospital & Diagnostic Laboratories, Blood Banks, Others), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET OVERVIEW

The global hepatitis test solution/diagnosis market size was anticipated to be valued at USD 3.34 billion in 2024, with a projected growth to USD 4.61 billion by 2033 at a CAGR of 4.1% during the forecast period from 2025 to 2033.

The term "hepatitis" refers to various liver infections. It is also divided into different types, hepatitis A, B and C. Hepatitis is diagnosed using blood tests for each virus and detection of antibodies associated with the virus. In addition, viral components, i.e. genetic material or body proteins, can be tested to determine the type of hepatitis.

The growth of this market is attributed to high prevalence of hepatitis worldwide, benefits offered by care devices and kits, and initiatives by governmental and non-governmental organizations. However, lack of NAT mandate in developing countries and high cost of NAT test is expected to restrict the growth of this market during the forecast period.

COVID-19 IMPACT

Market Growth Restrained by Pandemic due to Supply Chain Disruptions

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The outbreak of the COVID-19 pandemic was an unprecedented event that affected public health and led to a gradual increase number of hospitalizations. The coronavirus pandemic has increased the burden of disease and complicated several global for businesses, including health care, in 2020 and early 2021. This has led to some medical and diagnostic procedures being delayed or delayed. The market has been badly affected by the COVID-19 pandemic as it has affected several factors such as blood donation and other healthcare services that serve to screen hepatitis virus samples.

LATEST TRENDS

Increase In The Number Of Sick Patients Will Drive Market Growth

The increase in the number of sick patients is one of the biggest health problems in many countries of the world. Hepatitis is a viral disease an infection that can cause inflammation of the liver and, if left untreated, can lead to cirrhosis, liver failure and liver cancer. Hepatitis is a leading cause of liver disease and can have serious long-term health effects. Some of the main factors contributing to the increase in the number of patients are a lack of awareness about the disease and treatment options, as well as limited access to testing and diagnosis. However, increased awareness of hepatitis and disease screening initiatives by authorities, along with provision of cost-effective diagnostic tests by market players, are expected to increase product adoption.

Request a Free sample to learn more about this report

HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Hepatitis B, HCV, HAV, HDV, Others. Hepatitis B segment was dominant in 2022 and is expected to dominate the market share by 2032. Hepatitis B virus (HBV) is the leading cause of acute and chronic liver disease worldwide, causing about 1.4 million deaths annually.

By Application

Based on application the global market can be categorized into Hospital & Diagnostic Laboratories, Blood Banks, Others. The hospital segment accounted for a significant share of the business in 2022 and is projected to grow rapidly by 2032. This is due to the increased use of diagnostic tests for hepatitis in the hospital environment, which is expected to increase the number of patients and; providing better outcomes for hospitals. Increased access to healthcare covering chronic diseases and increased disease screening initiatives along with the availability of highly trained healthcare professionals are some of the other features driving the industry landscape.

DRIVING FACTORS

Increasing Growing Demand For Molecular Diagnostics In The Diagnosis to Boosts The Market Growth

The growing demand for molecular diagnostics in the diagnosis of HBV and HCV will significantly boost the growth of the market. Worldwide, nearly 600 hospital laboratories and 200 independent laboratories perform high-volume tests that require automated molecular diagnostic test platforms to simplify and facilitate sample preparation. Popular applications of molecular diagnostics include identification and profiling of infectious agents and quantification of pathogens to monitor treatment duration. Sales of molecular diagnostics for infectious diseases such as HBV and HCV represent a significant portion of the overall molecular diagnostics market. Real-time polymerase chain reaction (PCR) is the standard recommended molecular diagnostic method for HCV RNA and HBV DNA in clinical samples. Thus, the high potential in the application of molecular biology techniques in the clinical diagnosis of HBV and HCV will drive the hepatitis test solution/diagnosis market growth during the forecast period.

Growth of the Biotechnology And Biopharmaceutical Industries to Augment Market Growth

The demand for immunoassay instruments and accessories is high in the biotechnology and biopharmaceutical industries. As a result, growth in these industries is expected to support market growth during the forecast period. In these industries, the increase in the number of end users has forced many companies to launch new products and invest in the development of improved products. This is considered a positive indicator for the growth of the immunoassays market. Awareness of the benefits of hepatitis virus testing, which helps to plan the right course of treatment and prevention, is an important factor to accelerate market growth, as well as changes in lifestyle and eating habits, increasing side effects of drugs, excessive consumption of alcohol, the incidence increases viral hepatitis and autoimmune diseases, rise in consumer disposable income, rise in medical tourism and high growth in undiagnosed population are driving factors for the hepatitis testing solutions/diagnosis market. Moreover, technological advancement and modernization of the healthcare sector, increasing R&D activities in the healthcare sector, and growing emerging markets along with a growing geriatric population will continue to create new opportunities for the hepatitis testing solutions/diagnostics market during the forecast period of 2021-2028.

RESTRAINING FACTORS

High Cost And Lack Of Mandatory Regulations to Potentially Impede Market Growth

Rising cost of NAT (Nucleic Acid Amplification Testing) and lack of mandatory regulations for hepatitis virus testing by authorities in developing countries are the major factors, among others, hindering market growth and adding challenges to growth of the hepatitis testing solutions/diagnostics market during the said forecast period. Low penetration of diagnostic tests for HBV and HCV is one of the challenges restraining the growth of the market. The large population of undiagnosed individuals with hepatitis C infection indicates a low prevalence of hepatitis C diagnosis.

• Request a Free sample to learn more about this report

•  

HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET REGIONAL INSIGHTS

North America to Dominate the Market due to Increasing Number Of Hepatitis Testing Studies

The global market is segmented into North America (US and Canada), Europe (Germany, UK and Rest of Europe) and Rest of the World.  North America will dominate the hepatitis test solution/diagnosis market share in 2020 and this trend is expected to continue during the forecast period. The high share and rapid growth of this region is due to the increased prevalence of hepatitis and the increasing number of hepatitis testing studies and clinical trials in the U.S. America is considered to be the leading diagnostic market for hepatitis testing solutions in the coming years. The increase in bacterial infections and the adoption of clinical practices in the treatment of various diseases are driving the tremendous growth of the regional market. The availability of advanced diagnostic tools and high awareness of these products are the major factors driving the growth of the North American market. Increasing blood transfusion in North America has increased the need for hepatitis B diagnosis.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through Innovation and Market Expansion

The hepatitis test solution/diagnosis market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of wardrobe options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development, introducing innovative designs, materials, and smart features, catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.

List of Top Hepatitis Test Solution/Diagnosis Companies

• Abbott Laboratories (U.S.)
• Roche Diagnostics (Switzerland)
• Bio-Rad (U.S.)
• Siemens Healthineers (Germany)
• Diasorin (Italy)
• Qiagen (Netherlands)
• Biomérieux (France)
• Ortho Clinical Diagnostics (U.S.)

INDUSTRIAL DEVELOPMENT

July 2022: Roche announced the launch of the Elecsys HCV Duo immunoassay for the diagnostic test of hepatitis C. The Elecsys HCV Duo immunoassay is intended for the determination of hepatitis C virus (HCV) antigen and antibody status in a single human plasma or serum sample. The launch of this innovative dual antigen and antibody diagnostic test has helped the company expand its product portfolio and grow its business.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.